| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coya Therapeutics, Inc. (COYA) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. COYA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 10.0K | $45.4K | - | |
| Dir | 10.0K | $45.4K | - | |
| Dir | 10.0K | $45.4K | - | |
| Dir | 10.0K | $45.4K | - | |
| Dir | 10.0K | $45.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2024 | Snyder David S | Chief Financial Officer | Buy | 1,800 | $7.19 | $12,934.44 | +25.7% | -2.9% | -13.8% | |
| Nov 13, 2024 | Swaminathan Arun | Chief Executive Officer | Buy | 5,000 | $7.36 | $36,797.00 | +100.0% | -8.4% | -17.7% | |
| Nov 11, 2024 | Grossman Fred | Chief Medical Officer | Buy | 2,710 | $7.37 | $19,972.70 | New | -6.1% | -18.0% | |
| Nov 11, 2024 | Swaminathan Arun | Chief Executive Officer | Buy | 5,000 | $7.34 | $36,689.00 | New | -6.1% | -18.0% | |
| Aug 22, 2023 | Lee Ann | Director | Buy | 1,000 | $3.62 | $3,620.00 | +6.1% | +55.3% | +69.5% | |
| Jan 3, 2023 | Goldstein Dov A Md | Director | Buy | 10,000 | $0.00 | - | New | -12.9% | +48.2% | |
| Jan 3, 2023 | Villalobos Anabella | Director | Buy | 10,000 | $0.00 | - | New | -12.9% | +48.2% | |
| Jan 3, 2023 | Berman Howard | Chief Executive Officer | Buy | 10,000 | $0.00 | - | New | -12.9% | +48.2% | |
| Jan 3, 2023 | Hepner Adrian | Chief Medical Officer | Buy | 10,000 | $0.00 | - | New | -12.9% | +48.2% | |
| Jan 3, 2023 | Snyder David S | Chief Financial Officer | Buy | 7,000 | $0.00 | - | New | -12.9% | +48.2% |